Novelion Therapeutics Inc (NVLNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Operating Expenses | 6,017 | 7,403 | 8,926 | 3,811 | 2,782 |
| Operating Income | -6,017 | -7,403 | -8,926 | -3,811 | -2,782 |
| Interest Expense | -110 | -54 | -75 | 0 | 0 |
| Other Income | -144 | 2,234 | -13,037 | 136 | 103 |
| Pre-tax Income | -6,051 | -5,115 | -21,888 | -3,675 | -2,679 |
| Income Tax | -115 | 5 | 6 | 5 | 3 |
| Net Income Continuous | -5,936 | -5,120 | -21,894 | -3,680 | -2,682 |
| Net Income | $-5,936 | $-5,120 | $-21,894 | $-3,680 | $-2,682 |
| EPS Basic Total Ops | -0.56 | -0.48 | -2.07 | -0.30 | -0.25 |
| EPS Basic Continuous Ops | -0.56 | -0.48 | -2.07 | -0.33 | -0.25 |
| EPS Diluted Total Ops | -0.56 | -0.48 | -2.07 | -0.30 | -0.25 |
| EPS Diluted Continuous Ops | -0.56 | -0.48 | -2.07 | -0.33 | -0.25 |
| EBITDA(a) | $-5,993 | $-7,380 | $-8,888 | $-3,743 | $-2,641 |